SOUTH SAN FRANCISCO, Calif. & LOS ANGELES & SAN DIEGO--(BUSINESS WIRE)--Biocom California, the association representing the California life science industry, today announced the signing of a memorandum of understanding (MOU) with Bundesverband der Pharmazeutischen Industrie e.V. (BPI), Germany’s national industry association representing the pharmaceutical industry.

加州南旧金山、洛杉矶和圣地亚哥--（商业新闻短讯）--代表加州生命科学行业的协会Biocom California今天宣布与代表制药行业的德国国家行业协会Bundesverband der Pharmazeutischen Industrie e.V.（BPI）签署谅解备忘录（MOU）。

BPI is headquartered in Berlin and represents the interest of approximately 260 pharmaceutical and biotech companies in Germany..

BPI总部位于柏林，代表德国约260家制药和生物技术公司的利益。。

“At Biocom California, we strive to promote California’s life science industry by consistently broadening our network of industry leaders and creating new avenues for business, funding, and partnering opportunities by fostering international collaboration,” said Joe Panetta, president and CEO of Biocom California.

Biocom California总裁兼首席执行官乔·帕内塔（JoePanetta）表示：“在Biocom California，我们通过不断扩大行业领导者网络，通过促进国际合作，为业务、资金和合作机会创造新途径，努力促进加州的生命科学行业。”。

“With existing partnerships across Asia, Europe and Australia, our agreement with BPI ensures we continue to build global relationships with life science communities that create mutually beneficial opportunities for our member companies.”.

“通过与亚洲、欧洲和澳大利亚的现有合作伙伴关系，我们与BPI的协议确保我们继续与生命科学界建立全球关系，为我们的成员公司创造互利的机会。”。

The agreement between Biocom California and BPI is intended to drive growth, foster innovation and create new opportunities for member companies of both organizations. The parties will work together to facilitate access to funding prospects and regulatory access for their respective members, as well as enhance coordination between government officials who support the global life science industry.

Biocom California和BPI之间的协议旨在推动增长，促进创新，并为两家组织的成员公司创造新的机会。各方将共同努力，促进各自成员获得资金前景和监管渠道，并加强支持全球生命科学行业的政府官员之间的协调。

By bridging relationships between member companies of Biocom California and BPI, the collaboration creates more established communications channels that allow each region to learn more about regulatory, market and reimbursement systems of the U.S. and Germany..

通过弥合Biocom California和BPI成员公司之间的关系，该合作创造了更为成熟的沟通渠道，使每个地区都能更多地了解美国和德国的监管、市场和报销系统。。

About Bundesverband der Pharmazeutischen Industrie e.V. (BPI)

关于德国联邦制药工业协会（BPI）

BPI Germany is the strong alliance of pharmaceutical companies and represents the industry along the entire value chain in Germany and Europe. Our comprehensive range of services moves our members forward in their business activities.

BPI德国是制药公司的强大联盟，代表着德国和欧洲整个价值链的行业。。

With over 70 years of experience in drug research, development, authorization, manufacturing and marketing, BPI is Germany’s national industry association which represents the pharmaceutical industry with all its variety. Around 260 member companies comprise the whole spectrum of the pharmaceutical industry, ranging from multinational corporations to SMEs, Mid-Caps as well as Start-ups.

BPI在药物研究、开发、授权、制造和营销方面拥有70多年的经验，是德国的国家行业协会，代表了制药行业的所有种类。大约260家成员公司组成了整个制药行业，从跨国公司到中小企业、中型企业以及初创企业。

These companies ensure drug supply for all patients across the European Union and globally. In addition to our Berlin headquarters, BPI operates offices in the “EU Capital” Brussels. On top the BPI's regional associations represent the interests of pharmaceutical companies in the federal states..

这些公司确保欧盟和全球所有患者的药物供应。除了我们的柏林总部外，BPI还在“欧盟首都”布鲁塞尔设有办事处。最重要的是，BPI的地区协会代表了联邦各州制药公司的利益。。

The members benefit from a wide range of services and support. BPI provides exclusive analyses and fast information for its members, current topics are presented and discussed in more than 50 working groups. By providing information to decision-makers at federal, state, and EU level on the common interests of the industry, we help to shape the social and legal framework conditions for our industry..

会员受益于广泛的服务和支持。BPI为其成员提供独家分析和快速信息，目前的主题在50多个工作组中进行介绍和讨论。通过向联邦、州和欧盟层面的决策者提供有关行业共同利益的信息，我们有助于塑造行业的社会和法律框架条件。。

About Biocom California

关于Biocom California

Biocom California is the leader and advocate for California’s life science sector. We work on behalf of more than 1,800 members to drive public policy, build an enviable network of industry leaders, create access to capital, introduce cutting-edge STEM education programs and create robust value-driven purchasing programs..

Biocom California是加州生命科学领域的领导者和倡导者。我们代表1800多名成员推动公共政策，建立一个令人羡慕的行业领导者网络，创造资金渠道，引入尖端的STEM教育计划，并创建强大的价值驱动采购计划。。

Founded in 1995 in San Diego, Biocom California provides the strongest public voice to research institutions and companies that fuel the local and state-wide economy. Our goal is simple: to help our members produce novel solutions that improve the human condition. In addition to our San Diego headquarters, Biocom California operates core offices in Los Angeles and the San Francisco Bay Area, with satellite offices in Sacramento, Washington, D.C.

加州生物科技公司成立于1995年，位于圣地亚哥，为推动地方和全州经济的研究机构和公司提供最强有力的公众声音。我们的目标很简单：帮助我们的成员提出改善人类状况的新颖解决方案。除了圣地亚哥总部外，Biocom California在洛杉矶和旧金山湾区设有核心办事处，在华盛顿特区萨克拉门托设有卫星办事处。

and Tokyo. Our broad membership benefits apply to biotechnology, pharmaceutical, medical device, genomics and diagnostics companies of all sizes, as well as to research universities and institutes, clinical research organizations, investors and service providers..

和东京。我们广泛的会员利益适用于各种规模的生物技术、制药、医疗器械、基因组学和诊断公司，以及研究型大学和研究所、临床研究组织、投资者和服务提供商。。

For more information on Biocom California, please visit our website at www.biocom.org. Connect with us on LinkedIn, Facebook, and X (@BIOCOMCA).

有关加利福尼亚州Biocom的更多信息，请访问我们的网站www.Biocom.org。通过LinkedIn、Facebook和X（@BIOCOMCA）与我们联系。